BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9239401)

  • 1. Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts.
    Nagano H; Mitchell RN; Taylor MK; Hasegawa S; Tilney NL; Libby P
    J Clin Invest; 1997 Aug; 100(3):550-7. PubMed ID: 9239401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma.
    Nagano H; Libby P; Taylor MK; Hasegawa S; Stinn JL; Becker G; Tilney NL; Mitchell RN
    Am J Pathol; 1998 May; 152(5):1187-97. PubMed ID: 9588888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-16 deficiency suppresses the development of chronic rejection in murine cardiac transplantation model.
    Kimura N; Itoh S; Nakae S; Axtell RC; Velotta JB; Bos EJ; Merk DR; Gong Y; Okamura H; Nagamine CM; Adachi H; Kornfeld H; Robbins RC; Fischbein MP
    J Heart Lung Transplant; 2011 Dec; 30(12):1409-17. PubMed ID: 22055099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-10 (IL-10) augments allograft arterial disease: paradoxical effects of IL-10 in vivo.
    Furukawa Y; Becker G; Stinn JL; Shimizu K; Libby P; Mitchell RN
    Am J Pathol; 1999 Dec; 155(6):1929-39. PubMed ID: 10595923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-gamma alters the pathology of graft rejection: protection from early necrosis.
    Halloran PF; Miller LW; Urmson J; Ramassar V; Zhu LF; Kneteman NM; Solez K; Afrouzian M
    J Immunol; 2001 Jun; 166(12):7072-81. PubMed ID: 11390451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allografts.
    Koga N; Suzuki J; Kosuge H; Haraguchi G; Onai Y; Futamatsu H; Maejima Y; Gotoh R; Saiki H; Tsushima F; Azuma M; Isobe M
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2057-62. PubMed ID: 15374847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of recipient mast cells in acute and chronic cardiac allograft rejection in C57BL/6-KitW-sh/W-sh mice.
    Itoh S; Nakae S; Velotta JB; Kosuge H; Connolly A; Tsai M; Adachi H; Galli SJ; Robbins RC; Fischbein MP
    J Heart Lung Transplant; 2010 Apr; 29(4):401-9. PubMed ID: 19818646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor and recipient contributions of ICAM-1 and P-selectin in parenchymal rejection and graft arteriosclerosis: insights from double knockout mice.
    Räisänen-Sokolowski A; Glysing-Jensen T; Russell ME
    J Heart Lung Transplant; 1999 Aug; 18(8):735-43. PubMed ID: 10512519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of accelerated coronary atherosclerosis with short-term blockade of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in a heterotopic murine model of heart transplantation.
    Suzuki J; Isobe M; Yamazaki S; Horie S; Okubo Y; Sekiguchi M
    J Heart Lung Transplant; 1997 Nov; 16(11):1141-8. PubMed ID: 9402514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
    Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
    J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-interleukin-12/23p40 antibody attenuates chronic rejection of cardiac allografts partly via inhibition γδT cells.
    Wang S; Xu X; Xie A; Li J; Ye P; Liu Z; Wu J; Rui L; Xia J
    Clin Exp Immunol; 2012 Sep; 169(3):320-9. PubMed ID: 22861372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
    Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL
    Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
    Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
    Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary atherosclerosis in transplanted mouse hearts. III. Effects of recipient treatment with a monoclonal antibody to interferon-gamma.
    Russell PS; Chase CM; Winn HJ; Colvin RB
    Transplantation; 1994 May; 57(9):1367-71. PubMed ID: 7910422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern of graft- and host-specific MHC class II expression in long-term murine cardiac allografts: origin of inflammatory and vascular wall cells.
    Hasegawa S; Becker G; Nagano H; Libby P; Mitchell RN
    Am J Pathol; 1998 Jul; 153(1):69-79. PubMed ID: 9665467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitive diagnosis of cardiac allograft rejection by detection of cytokine transcription in situ.
    Suzuki J; Isobe M; Yamazaki S; Horie S; Okubo Y; Sekiguchi M
    Cardiovasc Res; 1998 Nov; 40(2):307-13. PubMed ID: 9893724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy.
    Mottram PL; Han WR; Purcell LJ; McKenzie IF; Hancock WW
    Transplantation; 1995 Feb; 59(4):559-65. PubMed ID: 7878761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cold ischemia induces isograft arteriopathy, but does not augment allograft arteriopathy in non-immunosuppressed hosts.
    Furukawa Y; Libby P; Stinn JL; Becker G; Mitchell RN
    Am J Pathol; 2002 Mar; 160(3):1077-87. PubMed ID: 11891204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disturbed MHC regulation in the IFN-gamma knockout mouse. Evidence for three states of MHC expression with distinct roles for IFN-gamma.
    Goes N; Sims T; Urmson J; Vincent D; Ramassar V; Halloran PF
    J Immunol; 1995 Nov; 155(10):4559-66. PubMed ID: 7594453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.